{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T20:40:42Z","timestamp":1794775242464,"version":"4.9.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,19]]},"abstract":"<jats:p>Heart failure (HF) poses a significant global health burden, necessitating a profound understanding of its multifaceted dimensions. This comprehensive review aims to unravel the etiology, decode pathophysiological mechanisms, navigate diagnostic modalities, explore pharmacological interventions, advocate lifestyle modifications, and chart the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction. The exploration of HF begins with an insightful journey into its diverse etiological factors, encompassing genetic predispositions, hypertension, and coronary artery disease. Delving into pathophysiological mechanisms, this review elucidates the intricate processes of cardiac remodeling, neurohormonal activation, and cellular dysfunction that underlie the progression of HF. Diagnostic modalities play a pivotal role in unraveling the mysteries of HF by examining advanced imaging techniques, biomarkers, and comprehensive clinical assessments. The pharmacological interventions section provides an in-depth analysis of traditional medications, such as diuretics and angiotensin-converting enzyme inhibitors, while highlighting the emergence of novel drug classes transforming HF management. Advocating lifestyle modifications emphasizes the crucial role of diet, exercise, smoking cessation, and alcohol moderation in enhancing patient outcomes. Lastly, the review delves into the promising horizon of emerging therapies, offering a glimpse into current research, innovative treatment approaches, and potential breakthroughs. As HF management faces challenges in patient compliance, healthcare access, and education, this comprehensive review aims to equip healthcare professionals and researchers with a holistic understanding of chronic cardiac dysfunction\u2019s intricacies. In conclusion, synthesizing key findings emphasizes the need for an integrated and multidimensional approach to effectively address the complex landscape of heart failure.<\/jats:p>","DOI":"10.1097\/md.0000000000036895","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T21:01:41Z","timestamp":1705698101000},"page":"e36895","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["A comprehensive review of heart failure: Unraveling the etiology, decoding pathophysiological mechanisms, navigating diagnostic modalities, exploring pharmacological interventions, advocating lifestyle modifications, and charting the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0249-1865","authenticated-orcid":false,"given":"Chukwuka","family":"Elendu","sequence":"first","affiliation":[{"name":"University of California, Santa Cruz, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dependable C.","family":"Amaechi","sequence":"additional","affiliation":[{"name":"Igbinedion University, Okada, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tochi C.","family":"Elendu","sequence":"additional","affiliation":[{"name":"Imo State University, Owerri, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Border-ere","family":"Fiemotonghan","sequence":"additional","affiliation":[{"name":"Jackson State University, MS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osinachi K.","family":"Okoye","sequence":"additional","affiliation":[{"name":"Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Awka, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chigozirim M.","family":"Agu-Ben","sequence":"additional","affiliation":[{"name":"Kharkiv National Medical University, Kharkiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel O.","family":"Onyekweli","sequence":"additional","affiliation":[{"name":"Obafemi Awolowo University, Ife, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas A.","family":"Amapu","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ikpegbu","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy","family":"Asekhauno","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Pius","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adediwura T.","family":"Bayo-Shodipo","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidera A.","family":"Okezie-Okoye","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurudeen","family":"Bello","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibuike","family":"Oguine","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Promise","family":"Edochie","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkechinyere","family":"Dike","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibirongbe","family":"Amos","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Asekhauno","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanitoluwa M.","family":"Wusu-Ejalonibu","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuella E.","family":"Ozigi","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace O.","family":"Otobo","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderinsola R.","family":"Olokodana","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiagozie P.","family":"Ayabazu","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael T.","family":"Nwafor","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandir J.","family":"Gonji","sequence":"additional","affiliation":[{"name":"Babcock University, Ilishan-Remo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otite","family":"Akpovona","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital NHS Foundation Trust, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temitope I.","family":"Awotoye","sequence":"additional","affiliation":[{"name":"Reddington Multispecialist Hospital, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutalib O.","family":"Ozigis","sequence":"additional","affiliation":[{"name":"University of Ilorin Teaching Hospital, Ilorin, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatosin","family":"Afolabi","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital NHS Foundation Trust, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omotayo S.","family":"Alabi","sequence":"additional","affiliation":[{"name":"University of Osun Teaching Hospital, Osogbo, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mololuwa","family":"Adebayo","sequence":"additional","affiliation":[{"name":"Ring Road State Hospital, Ibadan, Nigeria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250505","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/j.jvca.2020.07.016","article-title":"Heart failure with preserved ejection fraction: a comprehensive review and update of diagnosis, pathophysiology, treatment, and perioperative implications.","volume":"35","author":"Pagel","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R2-20250505","doi-asserted-by":"crossref","first-page":"1753944719840192","DOI":"10.1177\/1753944719840192","article-title":"A comprehensive review of chronic heart failure pharmacotherapy treatment approaches in African Americans.","volume":"13","author":"Tillman","year":"2019","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R3-20250505","doi-asserted-by":"crossref","first-page":"e34906","DOI":"10.1097\/MD.0000000000034906","article-title":"Heart failure and diabetes: understanding the bidirectional relationship.","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R4-20250505","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of heart failure.","volume":"11","author":"Schwinger","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"R5-20250505","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"R6-20250505","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/j.2040-4603.2016.tb00669.x","article-title":"Pathophysiology of heart failure.","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr Physiol"},{"key":"R7-20250505","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ejhf.1620","article-title":"Heart failure after treatment for breast cancer.","volume":"22","author":"Boekel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R8-20250505","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"R9-20250505","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/CIRCULATIONAHA.115.016704","article-title":"Anthracycline cardiotoxicity A new paradigm for an old classic.","volume":"131","author":"Groarke","year":"2015","journal-title":"Circulation"},{"key":"R10-20250505","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/hrt.2003.025254","article-title":"Prediction and prevention of sudden cardiac death in heart failure.","volume":"91","author":"Lane","year":"2005","journal-title":"Heart"},{"key":"R11-20250505","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cells9010242","article-title":"Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding.","volume":"9","author":"Simmonds","year":"2020","journal-title":"Cells"},{"key":"R12-20250505","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute.","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"key":"R13-20250505","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"key":"R14-20250505","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction.","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"R15-20250505","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","article-title":"Myocardial structure and function differ in systolic and diastolic heart failure.","volume":"113","author":"van Heerebeek","year":"2006","journal-title":"Circulation"},{"key":"R16-20250505","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ehf2.12267","article-title":"Genetic determinants of heart failure: facts and numbers.","volume":"5","author":"Czepluch","year":"2018","journal-title":"ESC Heart Failure"},{"key":"R17-20250505","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000134279.79571.73","article-title":"Anemia and its relationship to clinical outcome in heart failure.","volume":"110","author":"Anand","year":"2004","journal-title":"Circulation"},{"key":"R18-20250505","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure.","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"R19-20250505","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency.","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"R20-20250505","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairement worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"R21-20250505","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)61402-1","article-title":"Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.","volume":"385","author":"Gilbert","year":"2015","journal-title":"Lancet"},{"key":"R22-20250505","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.pmed.1001204","article-title":"Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.","volume":"9","author":"Boussageon","year":"2012","journal-title":"PLoS Med"},{"key":"R23-20250505","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SCGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"R24-20250505","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"R25-20250505","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"R26-20250505","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12933-019-0938-6","article-title":"Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completion.","volume":"18","author":"Packer","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"R27-20250505","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ageing\/afu138","article-title":"Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report.","volume":"43","author":"Turner","year":"2014","journal-title":"Age Ageing"},{"key":"R28-20250505","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(65)90211-1","article-title":"Catecholamin excretion and cardiac stores of norepinephrine in congestive heart failure.","volume":"39","author":"Chidsey","year":"1965","journal-title":"Am J Med"},{"key":"R29-20250505","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/HJH.0000000000001856","article-title":"Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction.","volume":"37","author":"Seravalle","year":"2019","journal-title":"J Hypertens"},{"key":"R30-20250505","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejheart.2004.03.018","article-title":"Altered hetero- and homeometric autoregulation in the terminally failing human heart.","volume":"7","author":"Brixius","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R31-20250505","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.RES.74.5.959","article-title":"The Failing Human Heart is unable to use the Frank-Starling Mechanism.","volume":"74","author":"Schwinger","year":"1994","journal-title":"Circ Res"},{"key":"R32-20250505","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.71.5.994","article-title":"Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work.","volume":"71","author":"Glower","year":"1985","journal-title":"Circulation"},{"key":"R33-20250505","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","article-title":"Molecular pathways underlying cardiac remodeling during pathophysiological stimulation.","volume":"122","author":"Kehat","year":"2010","journal-title":"Circulation"},{"key":"R34-20250505","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and \u03b2-adrenergic-receptor density in failing human hearts.","volume":"307","author":"Bristow","year":"1982","journal-title":"N Engl J Med"},{"key":"R35-20250505","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","article-title":"What is the role of beta-adrenergic signaling in heart failure?","volume":"93","author":"Lohse","year":"2003","journal-title":"Circ Res"},{"key":"R36-20250505","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0735-1097(94)00353-R","article-title":"Evidence for reduction of norepinephrine uptake sites in the failing human heart.","volume":"25","author":"B\u00f6hm","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R37-20250505","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1172\/JCI117219","article-title":"Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs.","volume":"93","author":"Ishikawa","year":"1994","journal-title":"J Clin Invest"},{"key":"R38-20250505","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3949\/ccjm.73.Suppl_3.S19","article-title":"The role of vasopressin in congestive heart failure.","volume":"73","author":"Goldsmith","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"R39-20250505","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1009783929020","article-title":"Angiotensin II-forming systems in cardiovascular diseases.","volume":"3","author":"Urata","year":"1998","journal-title":"Heart Failure Rev"},{"key":"R40-20250505","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.HYP.0000028001.65341.AA","article-title":"Angiotensin II induces catecholamine release by direct ganglionic excitation.","volume":"40","author":"Dendorfer","year":"2002","journal-title":"Hypertension"},{"key":"R41-20250505","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/hrt.76.3_Suppl_3.36","article-title":"The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.","volume":"76","author":"Richards","year":"1996","journal-title":"Heart"},{"key":"R42-20250505","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.110.979500","article-title":"Natriuretic peptide testing in heart failure.","volume":"123","author":"Kim","year":"2011","journal-title":"Circulation"},{"key":"R43-20250505","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice.","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"R44-20250505","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-5273(99)00186-2","article-title":"The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1.","volume":"72","author":"Sharma","year":"2000","journal-title":"Int J Cardiol"},{"key":"R45-20250505","first-page":"158","article-title":"Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha.","volume":"12","author":"Amir","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"R46-20250505","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.101.14.1679","article-title":"Myofilament calcium regulation in human myocardium.","volume":"101","author":"Hajjar","year":"2000","journal-title":"Circulation"},{"key":"R47-20250505","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00424-003-1163-3","article-title":"Ser 16, but not Thr 17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium.","volume":"447","author":"Brixius","year":"2003","journal-title":"Pflugers Arch"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T20:03:28Z","timestamp":1746475408000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036895","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}